Metraipolis › archive › dc_3bbf97d68d57
Translating evidence into practice: adapting TrialGPT for real-world clinical trial eligibility screening — Europe PMC PMID:41637159
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41637159
- DOI
- 10.1093/jamia/ocag006
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-08T03:25:08.259Z
- SHA-256 of the archived text
295b70d8b64cdf09f9b82de6947fa1e726266b3358301df35137459146002b81- Stable URL of this page
https://metraipolis.com/documento/dc_3bbf97d68d57
How to cite
Translating evidence into practice: adapting TrialGPT for real-world clinical trial eligibility screening — Europe PMC PMID:41637159 — Europe PMC (en), https://europepmc.org/article/MED/41637159 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_3bbf97d68d57 (Metraipolis archive dc_3bbf97d68d57, sha256 295b70d8b64cdf09f9b82de6947fa1e726266b3358301df35137459146002b81)
BibTeX
@misc{dc3bbf97d68d57,
title = {Translating evidence into practice: adapting TrialGPT for real-world clinical trial eligibility screening — Europe PMC PMID:41637159},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41637159},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_3bbf97d68d57; sha256 295b70d8b64cdf09f9b82de6947fa1e726266b3358301df35137459146002b81},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41637159. Agents can read the archived copy with the MCP tool read_document.